Ignite Creation Date:
2024-05-05 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372502
Status:
COMPLETED
Last Update Posted:
2009-01-14
First Post:
2006-09-06
Brief Title:
Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation
Sponsor:
National Institute of General Medical Sciences NIGMS
Organization:
National Institute of General Medical Sciences NIGMS
Study Overview
Official Title:
Lactate Assessment in the Treatment of Early Sepsis The LactATES Trial
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LactATES
Brief Summary:
The purpose of this study is to determine if there is equivalence between two different methods of treating patients with severe bloodstream infection called sepsis We will randomly assign patients to one of two treatment methods One of the treatment methods is the current standard of care and uses an infrared sensor on the end of a catheter to determine the adequacy of treatment The second treatment method is identical to the first but instead of the infrared sensor a blood test that is performed as a part of standard care with blood drawn from the catheter will be used to determine the adequacy of treatment This study will attempt to determine an easier method of guiding treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None